What is Haoxi Health Technology Limited Class A Ordinary Shares?
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China.
HAO · Verdict
Moderate reward · moderate risk
HAO stands out on balance sheet and volatility, but watch the valuation signal.
Based on 88% data coverage
HAO · Verdict
Interest covered 91.2×
Above average
Rev +5.1% CAGR · earnings +58.7%
Below average
12% net margin · 27% ROE
Model-based scoring. For information only — not financial advice.
Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, including online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help advertisers acquire, convert, and retain consumers on various online media platforms. The company is listed on the NASDAQ in USA, operating in the Communication Services sector, with a market capitalisation of 74.30M, and a P/E ratio of 0.9x.
The scoring profile indicates limited reward potential at this time, with growth and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.